THORATEC CORP Uncategorized Contracts & Agreements
41 Contracts & Agreements
- [THORATEC LETTERHEAD] [ ], 2015 (Filed With SEC on July 22, 2015)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 2, 2012)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on May 8, 2012)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on November 7, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on May 3, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on November 4, 2010)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on May 25, 2010)
- CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Filed With SEC on May 5, 2010)
- CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Filed With SEC on May 5, 2010)
- As adjusted (Filed With SEC on May 14, 2009)
- As adjusted (Filed With SEC on May 14, 2009)
- SUPPORT AGREEMENT (Filed With SEC on February 13, 2009)
- SUPPORT AGREEMENT (Filed With SEC on February 13, 2009)
- Current assets (Filed With SEC on May 8, 2008)
- Current assets (Filed With SEC on May 8, 2008)
- Current assets (Filed With SEC on May 10, 2007)
- Current assets (Filed With SEC on May 10, 2007)
- Current assets (Filed With SEC on May 10, 2007)
- Exhibit No (Filed With SEC on December 4, 2006)
- FIRST AMENDMENT TO OFFER LETTER AGREEMENT (Filed With SEC on May 16, 2006)
- Current assets (Filed With SEC on May 11, 2006)
- Current assets (Filed With SEC on May 11, 2006)
- Current assets (Filed With SEC on May 11, 2006)
- Circulatory Support Products. Our circulatory support products include VADs for the short, intermediate, and long-term treatment of advanced HF. In addition, we have developed... (Filed With SEC on March 16, 2006)
- Exhibit No (Filed With SEC on September 8, 2005)
- ConsultingAgreement (Filed With SEC on August 19, 2005)
- Current assets (Filed With SEC on May 11, 2005)
- Current assets (Filed With SEC on May 11, 2005)
- Current assets (Filed With SEC on May 11, 2005)
- For the Fiscal Year Ended (Filed With SEC on March 16, 2005)
- For the Fiscal Year Ended (Filed With SEC on March 16, 2005)
- Circulatory Support Products. Our circulatory support products include VADs for the short-term and long-term treatment of congestive heart failure. Our products address more... (Filed With SEC on March 17, 2004)
- Circulatory Support Products. Our circulatory support products include VADs for the short-term and long-term treatment of congestive heart failure. Our products address more... (Filed With SEC on March 17, 2004)
- Circulatory Support Products. Our circulatory support products include VADs for the short-term and long-term treatment of congestive heart failure. Our products address more... (Filed With SEC on March 17, 2004)
- Circulatory Support Products. Our circulatory support products include VADs for the short-term and long-term treatment of congestive heart failure. Our products address more... (Filed With SEC on March 17, 2004)
- Circulatory Support Products. Our circulatory support products include VADs for the short-term and long-term treatment of congestive heart failure. Our products address more... (Filed With SEC on March 17, 2004)
- Exhibit No (Filed With SEC on July 21, 2003)
- Part I. Financial Information (Filed With SEC on May 13, 2003)
